In the latest trading session,, 1.08 million Lexaria Bioscience Corp (NASDAQ:LEXX) shares changed hands as the company’s beta touched 0.94. With the company’s most recent per share price at $1.01 changed hands at -$0.04 or -3.81% at last look, the market valuation stands at $19.68M. LEXX’s current price is a discount, trading about -333.66% off its 52-week high of $4.38. The share price had its 52-week low at $0.92, which suggests the last value was 8.91% up since then.
Analysts gave the Lexaria Bioscience Corp (LEXX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended LEXX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Lexaria Bioscience Corp (NASDAQ:LEXX) trade information
Instantly LEXX was in red as seen in intraday trades today. With action 5.11%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -51.90%, with the 5-day performance at 5.11% in the green. However, in the 30-day time frame, Lexaria Bioscience Corp (NASDAQ:LEXX) is -6.05% down.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 21.61%. The 2025 estimates are for Lexaria Bioscience Corp earnings to decrease by -32.98%, but the outlook for the next 5-year period is at -18.14% per year.
LEXX Dividends
Lexaria Bioscience Corp is expected to release its next quarterly earnings report in July.
INVENOMIC CAPITAL MANAGEMENT LP holds the second largest percentage of outstanding shares, with 3.7067% or 0.51 million shares worth $1.43 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were NORTHERN LIGHTS FUND TRUST II-Invenomic Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 199.02 shares estimated at $0.2 million under it, the former controlled 0.25% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.15% of the shares, roughly 117.67 shares worth around $0.12 million.